Active Pharmaceutical Ingredient

Natalizumab

Also known as: Tysabri

CAS: 189261-10-7 Humanized Monoclonal Antibody Injection / IV / USP GMP Certified Aurangabad, Maharashtra, India
Natalizumab API — Mediocon Inc
Natalizumab — Pharmaceutical Grade API

Product Overview

CAS No: 189261-10-7  |  MF: C₆₄₈₄H₁₀₀₁₈N₁₇₄₄O₂₀₂₂S₄₄  |  MW: ~149,000 Da

Mirtazapine is a pharmaceutical-grade active ingredient classified as Humanized Monoclonal Antibody. Mediocon Inc supplies high-purity Mirtazapine API conforming to Injection / IV / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

  • Anti-α4 integrin monoclonal antibody
  • IV / USP injection grade
  • Full CoA and MSDS documentation
  • GMP certified biologic manufacturing

Applications

  • Relapsing-remitting multiple sclerosis
  • Crohn's disease (moderate to severe)
  • Prevention of disability progression in MS

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameNatalizumab
Also Known AsTysabri
CAS Number189261-10-7
Chemical NameAnti-α4-integrin humanized IgG4 monoclonal antibody
Molecular FormulaC₆₄₈₄H₁₀₀₁₈N₁₇₄₄O₂₀₂₂S₄₄
Molecular Weight~149,000 Da
CategoryNaSSA Antidepressant
AppearanceClear to slightly opalescent, colorless to slightly yellow solution
SolubilitySoluble in aqueous buffered solution
GradeInjection / IV / USP

Analytical Specifications

ParameterSpecification
AssayNLT 95.0% (protein content)
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?